Clinical Overview
Valproic acid (and its derivatives divalproex sodium) is an anticonvulsant with mood-stabilizing properties indicated for epilepsy, bipolar disorder, and migraine prevention. It is considered a first-line mood stabilizer for bipolar disorder and is particularly effective for manic episodes, mixed states, and rapid cycling. It has a broad spectrum of activity but requires careful monitoring due to potential serious side effects.
Primary Clinical Applications
Valproic acid is indicated for complex partial seizures, absence seizures, manic episodes of bipolar disorder, and migraine prophylaxis. It is particularly effective for rapid cycling bipolar disorder, mixed episodes, and patients with comorbid substance abuse. It may also be used for maintenance therapy in bipolar disorder.
Mechanism and Clinical Benefits
Valproic acid enhances GABA neurotransmission, blocks voltage-gated sodium channels, and affects multiple other neurotransmitter systems. Its mood-stabilizing effects may involve modulation of protein kinase C, gene expression, and neuroprotective mechanisms. The broad mechanism provides efficacy across multiple psychiatric and neurological conditions.
Monitoring Requirements
Valproic acid requires regular monitoring of liver function, complete blood count, and serum levels due to risks of hepatotoxicity, thrombocytopenia, and other serious adverse effects. Therapeutic drug monitoring is essential with target levels of 50-125 mcg/mL for mood disorders. Special attention is needed for teratogenic risks in women of childbearing potential.
Prescribing Information
Dosing & Administration
Bipolar Disorder – Manic Episodes:
- Initial: 750 mg daily in divided doses
- Titration: Increase rapidly to achieve therapeutic levels
- Range: 1000-3000 mg daily
- Target level: 50-125 mcg/mL
Epilepsy:
- Initial: 10-15 mg/kg/day
- Maintenance: 30-60 mg/kg/day
- Maximum: 60 mg/kg/day
Migraine Prophylaxis:
- Initial: 250 mg twice daily
- Range: 500-1000 mg daily
- Extended release: 500-1000 mg once daily
Administration:
- Take with food to reduce GI upset
- Divide immediate-release doses 2-3 times daily
- Extended-release: Once daily, swallow whole
- Regular monitoring of serum levels
Indications
- Complex partial seizures
- Simple and complex absence seizures
- Manic episodes associated with bipolar disorder
- Migraine prophylaxis
Contraindications
- Hepatic disease or significant hepatic dysfunction
- Known mitochondrial disorders (POLG mutations)
- Hypersensitivity to valproic acid
- Urea cycle disorders
Warnings & Precautions
- Boxed Warning: Hepatotoxicity (potentially fatal), teratogenicity, pancreatitis
- Hepatotoxicity: Monitor liver function regularly, especially first 6 months
- Teratogenicity: Major birth defects, avoid in pregnancy when possible
- Pancreatitis: Life-threatening, monitor for symptoms
- Thrombocytopenia: Monitor platelet count
- Hyperammonemia: Can cause encephalopathy
- Suicidal thoughts: Monitor for behavioral changes
Drug Interactions
- Lamotrigine: Valproic acid significantly increases lamotrigine levels
- Carbamazepine: Bidirectional interactions, monitor levels
- Phenytoin: Displaces from protein binding, monitor free levels
- Aspirin: Increases valproic acid levels and bleeding risk
- Topiramate: Increased risk of hyperammonemia and encephalopathy
Adverse Reactions
Common (>10%):
- Nausea, vomiting, diarrhea, dizziness, somnolence
- Weight gain, hair loss, tremor
Serious:
- Hepatotoxicity, pancreatitis, thrombocytopenia
- Hyperammonemia, birth defects
Long-term:
- Weight gain, hair loss, osteoporosis, polycystic ovary syndrome
Special Populations
- Women of childbearing age: High teratogenic risk, use effective contraception
- Pregnancy: Category D/X – avoid if possible, high risk of birth defects
- Hepatic Impairment: Contraindicated in hepatic disease
- Elderly: Start with lower doses, monitor for drug interactions
- Monitoring: LFTs, CBC, ammonia, therapeutic drug levels
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
